Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Weber

Showing results (111-120 of 252) with videos related to

Pageof 26
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 3, 2009
Infrequent replication of parvovirus B19 and erythrovirus genotypes 2 and 3 among HIV-infected patients with chronic anemiaTristan Ferry, Bernard Hirschel, Thanh Dang, et al.
Lancet (London, England)|August 2, 2005
Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort studyJonathan A C Sterne, Miguel A Hernán, Bruno Ledergerber, et al.
AIDS (London, England)|March 22, 2008
Respiratory viruses in HIV-infected patients with suspected respiratory opportunistic infectionJorge Garbino, Sarra Inoubli, Erik Mossdorf, et al.
Molecular & Cellular Proteomics : MCP|February 23, 2017
<i>In Vivo</i> and <i>in Vitro</i> Proteome Analysis of Human Immunodeficiency Virus (HIV)-1-infected, Human CD4<sup>+</sup> T CellsJohannes Nemeth, Valentina Vongrad, Karin J Metzner, et al.
Antiviral Therapy|September 6, 2002
Residual cell-associated unspliced HIV-1 RNA in peripheral blood of patients on potent antiretroviral therapy represents intracellular transcriptsMarek Fischer, Joseph K Wong, Doris Russenberger, et al.
Plos One|July 15, 2011
Reappearance of minority K103N HIV-1 variants after interruption of ART initiated during primary HIV-1 infectionKarin J Metzner, Christine Leemann, Francesca Di Giallonardo, et al.
Plos One|December 17, 2009
Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007Marie Ballif, Bruno Ledergerber, Manuel Battegay, et al.
AIDS (London, England)|October 18, 2005
Plasma leptin levels in men are not related to the development of lipoatrophy during antiretroviral therapyDorothea Wunder, Nick A Bersinger, Christoph Fux, et al.
AIDS (London, England)|July 20, 2002
Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count > 350 x 10(6) /lMilos Opravil, Bruno Ledergerber, Hansjakob Furrer, et al.
Antiviral Therapy|September 13, 2005
Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort studyJim Young, Rainer Weber, Martin Rickenbach, et al.
Pageof 26

Showing results (111-120 of 252) with videos related to

Sort By:
Pageof 26
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 3, 2009
Infrequent replication of parvovirus B19 and erythrovirus genotypes 2 and 3 among HIV-infected patients with chronic anemiaTristan Ferry, Bernard Hirschel, Thanh Dang, et al.
Lancet (London, England)|August 2, 2005
Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort studyJonathan A C Sterne, Miguel A Hernán, Bruno Ledergerber, et al.
AIDS (London, England)|March 22, 2008
Respiratory viruses in HIV-infected patients with suspected respiratory opportunistic infectionJorge Garbino, Sarra Inoubli, Erik Mossdorf, et al.
Molecular & Cellular Proteomics : MCP|February 23, 2017
<i>In Vivo</i> and <i>in Vitro</i> Proteome Analysis of Human Immunodeficiency Virus (HIV)-1-infected, Human CD4<sup>+</sup> T CellsJohannes Nemeth, Valentina Vongrad, Karin J Metzner, et al.
Antiviral Therapy|September 6, 2002
Residual cell-associated unspliced HIV-1 RNA in peripheral blood of patients on potent antiretroviral therapy represents intracellular transcriptsMarek Fischer, Joseph K Wong, Doris Russenberger, et al.
Plos One|July 15, 2011
Reappearance of minority K103N HIV-1 variants after interruption of ART initiated during primary HIV-1 infectionKarin J Metzner, Christine Leemann, Francesca Di Giallonardo, et al.
Plos One|December 17, 2009
Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007Marie Ballif, Bruno Ledergerber, Manuel Battegay, et al.
AIDS (London, England)|October 18, 2005
Plasma leptin levels in men are not related to the development of lipoatrophy during antiretroviral therapyDorothea Wunder, Nick A Bersinger, Christoph Fux, et al.
AIDS (London, England)|July 20, 2002
Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count > 350 x 10(6) /lMilos Opravil, Bruno Ledergerber, Hansjakob Furrer, et al.
Antiviral Therapy|September 13, 2005
Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort studyJim Young, Rainer Weber, Martin Rickenbach, et al.
Pageof 26